INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 65 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $14,000 | -6.7% | 14,176 | 0.0% | 0.00% | – |
| Q3 2019 | $15,000 | -42.3% | 14,176 | 0.0% | 0.00% | – |
| Q2 2019 | $26,000 | -3.7% | 14,176 | 0.0% | 0.00% | – |
| Q1 2019 | $27,000 | +58.8% | 14,176 | 0.0% | 0.00% | – |
| Q4 2018 | $17,000 | -55.3% | 14,176 | 0.0% | 0.00% | – |
| Q3 2018 | $38,000 | +40.7% | 14,176 | 0.0% | 0.00% | – |
| Q2 2018 | $27,000 | -10.0% | 14,176 | 0.0% | 0.00% | – |
| Q1 2018 | $30,000 | +3.4% | 14,176 | 0.0% | 0.00% | – |
| Q4 2017 | $29,000 | -70.4% | 14,176 | -80.8% | 0.00% | -100.0% |
| Q3 2017 | $98,000 | +28.9% | 73,916 | +51.9% | 0.00% | +100.0% |
| Q2 2017 | $76,000 | -31.5% | 48,666 | +41.1% | 0.00% | -50.0% |
| Q1 2017 | $111,000 | +136.2% | 34,490 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $47,000 | – | 34,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $7,561,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $1,756,000 | 0.24% |
| EAM Investors, LLC | 840,556 | $1,000,000 | 0.22% |
| Gratus Capital, LLC | 1,249,248 | $1,487,000 | 0.16% |
| Ally Bridge Group (NY) LLC | 86,242 | $103,000 | 0.07% |
| MARINER INDEPENDENT ADVISOR NETWORK, LLC | 1,252,822 | $1,491,000 | 0.06% |
| Bleichroeder LP | 250,000 | $298,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 324,784 | $386,000 | 0.05% |
| Polar Capital Holdings Plc | 5,000,000 | $5,950,000 | 0.04% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $649,000 | 0.03% |